Ivo De Wever
- Pulmonary and Respiratory Medicine top 1%
- Surgery top 2%
- Rheumatology top 0.5%
- Oncology top 5%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Raf SciotPaola Dal CinHerman Van den BergheM. StasMaria Dêbiec‐RychterStefaan MulierGiovanni TalliniG Marchal
- Topics
- Sarcoma Diagnosis and Treatment (42 papers)Soft tissue tumor case studies (17 papers)Tumors and Oncological Cases (14 papers)
- Partner nations
- BelgiumUnited StatesItaly
In The Last Decade
Ivo De Wever
104 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Pulmonary and Respiratory Medicine 2.3k
- Surgery 1.2k
- Rheumatology 1.2k
- Oncology 815
- Pathology and Forensic Medicine 639
Countries citing papers authored by Ivo De Wever
This map shows the geographic impact of Ivo De Wever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivo De Wever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivo De Wever more than expected).
Fields of papers citing papers by Ivo De Wever
This network shows the impact of papers produced by Ivo De Wever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivo De Wever. The network helps show where Ivo De Wever may publish in the future.
Co-authorship network of co-authors of Ivo De Wever
This figure shows the co-authorship network connecting the top 25 collaborators of Ivo De Wever. A scholar is included among the top collaborators of Ivo De Wever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivo De Wever. Ivo De Wever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 160 | |
| 3 | Genomic profiling discloses differences in imatinib-resistant gastrointestinal stromal tumors (GIST) with primary KIT exon 9 or KIT exon 11 mutations | 1 |
| 4 | 25 | |
| 5 | 17 | |
| 6 | 55 | |
| 7 | 9 | |
| 8 | 12 | |
| 9 | 64 | |
| 10 | 58 | |
| 11 | 25 | |
| 12 | Histopathological validation of lymph node staging in cancer of the esophagus and gastroesophageal junction with FDG-PET scan: a prospective study based on primary surgery with extensive lymphadenectomy | 3 |
| 13 | Clinical relevance of whole body FDG-PET (WB-PET) in recurrent malignant melanoma | 1 |
| 14 | 23 | |
| 15 | 13 | |
| 16 | 128 | |
| 17 | 46 | |
| 18 | Prognostic significance of nm23-protein expression in malignant melanoma | 1 |
| 19 | 3 | |
| 20 | 43 |
About Ivo De Wever
Ivo De Wever is a scholar working on Gastroenterology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 4.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (42 papers), Soft tissue tumor case studies (17 papers) and Tumors and Oncological Cases (14 papers). The work is most often cited by research in Gastroenterology (561 citations), Rheumatology (1.2k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Ivo De Wever has collaborated with scholars based in Belgium, United States and Italy. Frequent co-authors include Raf Sciot, Paola Dal Cin, Herman Van den Berghe, M. Stas, Maria Dêbiec‐Rychter, Stefaan Mulier, Giovanni Tallini, G Marchal, Yicheng Ni and Yi Miao. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.